Verified peer comparison
ALX Oncology Holdings vs ARS Pharmaceuticals Financial Comparison
Direct answer
ALX Oncology Holdings and ARS Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- ALX Oncology Holdings Revenue
- 0 USD
- ARS Pharmaceuticals Revenue
- 84,278,000 USD
- ALX Oncology Holdings Operating income
- -104,021,000 USD
- ARS Pharmaceuticals Operating income
- -179,448,000 USD